Literature DB >> 3002260

Herpes simplex virus vaccines.

B Meignier, B Roizman.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3002260     DOI: 10.1016/s0166-3542(85)80036-x

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


× No keyword cloud information.
  3 in total

1.  Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.

Authors:  A B Nesburn; R L Burke; H Ghiasi; S Slanina; S Bahri; S L Wechsler
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

Review 2.  Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy.

Authors:  Kaitlyn J Kelly; Joyce Wong; Yuman Fong
Journal:  Expert Opin Investig Drugs       Date:  2008-07       Impact factor: 6.206

3.  A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer.

Authors:  Yuman Fong; Teresa Kim; Amit Bhargava; Larry Schwartz; Karen Brown; Lynn Brody; Anne Covey; Matthias Karrasch; George Getrajdman; Axel Mescheder; William Jarnagin; Nancy Kemeny
Journal:  Mol Ther       Date:  2008-11-18       Impact factor: 11.454

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.